PRINCETON, N.J., Jan. 26, 2012 /PRNewswire/ -- BullMarket.com
(http://www.bullmarket.com) ("BMR"), an online investment
newsletter focused on long-term growth and income-generating
stocks, has provided subscribers with coverage of several small-cap
med-tech stocks, including Align Technology (Nasdaq: ALGN), Zeltiq
Aesthetics (Nasdaq: ZLTQ), Natus Medical (Nasdaq: BABY), Conceptus
(Nasdaq: CPTS), ArthroCare (Nasdaq: ARTC) and Cardiovascular
Systems (Nasdaq: CSII).
In addition to its daily newsletter and Recommended List of
stocks, BMR publishes six earnings preview reports each quarter and
several special reports each year. Its annual "High Yield" special
report comes out before the new year, while its MLP special report
comes out mid-year.
As a subscriber, you'll also gain access to our Recommended List
of stocks, which from the start of 2008 until the end of 2011 was
up 33.3%, compared with a -14.4% return for the S&P 500, a
47.7% outperformance.
Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/pr/?refer=BMR2301
BMR looked at the following topics, among others:
-- Can Align continue its straight path of strong growth? Does
the Cadent acquisition look like a good one?
-- Does Zeltiq Aesthetics look like it could be the next
Intuitive Surgical (Nasdaq: ISRG) with its CoolSculpting
procedure?
-- After a weak 2011, does Natus Medical look poised to get back
on track in 2012?
-- Do ArthroCare and/or Conceptus look like solid turnaround
candidates?
-- Does Cardiovascular Systems' treatment for peripheral artery
disease (PAD) look like it will be a winner for investors?
About BullMarket.com:
Launched in 1997, BullMarket.com has a strong track record of
creating wealth for its subscribers by providing sound, long-term
investing advice. The BullMarket.com Recommended List includes
about 50 companies across all major industries, including
Financials, Healthcare, Energy, Technology, and Retail, among
others. BullMarket.com is one of the oldest continuously published
investment newsletters online, and its Recommended List has
consistently outperformed the major market indices.
NOTE: This release was published by Indie Research Advisors, LLC
(CRD #131926), a registered investment advisor with the NASD and
State of NJ. Past performance does
not guarantee future results. Investors should always research
companies and securities before making any investments. Nothing
herein should be construed as an offer or solicitation to buy or
sell any security.
Contact:
Indie Research Advisors, LLC
Marcie Martin, +1-888-278-5515
SOURCE Indie Research Advisors, LLC